New head. Newer thinking
Once set to be the largest domestic pharma player, Cipla lost out to more aggressive firms. Its new CEO is set to give the conservative company a fresh lease of life.
Once set to be the largest domestic pharma player, Cipla lost out to more aggressive firms. Its new CEO is set to give the conservative company a fresh lease of life.